ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Chronic Infection by Hepatitis C Virus and the Development of Transplant Glomerulopathy.

D. Regidor,1 S. Alexandru,5 M. Martínez,3 N. Polanco,4 E. González,4 A. Serrano,2 J. Morales.4

1Nephrology, H.Virgen de la Salud, Toledo, Spain
2Immunology, Instituto de Investigación H. Doce de Octubre, Madrid, Spain
3Pathology, H.Doce de Octubre, Madrid, Spain
4Nephrology, H.Doce de Octubre, Madrid, Spain
5Nephrology, H.Rey Juan Carlos, Madrid, Spain.

Meeting: 2016 American Transplant Congress

Abstract number: A251

Keywords: Biopsy, Hepatitis C, Risk factors, Survival

Session Information

Session Name: Poster Session A: Long Term Outcomes in Kidney Transplantation

Session Type: Poster Session

Date: Saturday, June 11, 2016

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

OBJETIVE: To demonstrate that chronic infection with the hepatitis C virus (HCV) is a risk factor for the development of transplant glomerulopathy in a large sample of kidney biopsies analyzed by electron microscopy, and to demonstrate its negative impact on graft survival.

METHODS: Retrospective analysis, all biopsy samples of renal grafts with the diagnosis of chronic graft dysfunction, conducted between 2000 and 2014 in Madrid at 12 de Octubre Hospital were collected. 229 in total. Those in which histological study was carried out immunofluorescence (IF) and electron microscopy (EM) were selected. The work was divided in two phases: Firstly, a case control study: samples from 119 patients with chronic graft dysfunction were collected and the presence for HCV and Transplant Glomerulopathy (TG) was assessed. Secondly, a retrospective cohort study: samples from patients with TG diagnosed by EM and IF were collected.

RESULTS: In the sample of 119 patients with chronic graft dysfunction diagnosed by ME there were no differences in the immunological characteristics of patients with and without TG. HCV was a risk factor for developing TG with an OR=7.20 (2.47 to 21.01). No significant association was found of C4d, DSA, anti-HLA and history of acute rejection, with the TG, although it is evident the DSA as a risk factor for GT with an OR = 1.71 (1.06 to 2, 76). An error of type b for low power of the sample can explain the absence of this association. Patients with chronic graft dysfunction and HCV + showed significantly worse graft survival than the HCV-.

All patients who presented ultrastructural diagnosis of TG (57) were divided into two cohorts based on status for HCV. Significant differences between HCV+ / HCV- patients concerning the presence of interstitial fibrosis and tubular atrophy degree of the samples were found, being higher in the HCV+ patients. TG+ HCV+ patients significantly showed worse graft survival.

CONCLUSIONS: Chronic HCV infection is a risk factor for transplant glomerulopathy diagnosed by electron microscopy, showing a lower graft survival after diagnosis by biopsy, and even lower when associated with HCV+, being this the longest published series of renal grafts with TG diagnosed by ME.

CITATION INFORMATION: Regidor D, Alexandru S, Martínez M, Polanco N, González E, Serrano A, Morales J. Chronic Infection by Hepatitis C Virus and the Development of Transplant Glomerulopathy. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Regidor D, Alexandru S, Martínez M, Polanco N, González E, Serrano A, Morales J. Chronic Infection by Hepatitis C Virus and the Development of Transplant Glomerulopathy. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/chronic-infection-by-hepatitis-c-virus-and-the-development-of-transplant-glomerulopathy/. Accessed May 21, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences